AI Insights · Timothy · July 2023
Top 5 Medical Apps on Android in Egypt: Q2 2023 Performance
Explore the performance of the top 5 medical apps on Android in Egypt during Q2 2023, including weekly downloads, active users, and revenue trends.
During the second quarter of 2023, the top 5 medical apps on the Android platform in Egypt exhibited diverse performance trends in terms of weekly downloads and active users. Here’s a detailed look at the metrics for each app.
Altibbi from ALTIBBI saw its weekly downloads fluctuate throughout the quarter, peaking at 8.7K in the week of April 24 and hitting a low of 6.2K in the week of June 19. Active users for the app maintained a steady trend, starting at 17.7K in late March and gradually increasing to 23.3K in early June before stabilizing around 21.8K by the end of the quarter.
Elezaby pharmacy experienced significant variations in weekly downloads, with a notable peak of 8.4K in the week of April 24. The app's active user base also showed a dynamic pattern, starting at 17.8K in late March, reaching up to 24.5K in the week of April 24, and ending the quarter with 21.6K active users.
Vezeeta - Doctors & Pharmacy had a relatively stable download count, ranging from 1.1K to 2.2K throughout the quarter. The app's active users saw a decline from 65.3K in early April to 47.5K by the end of June, indicating a gradual decrease in user engagement over the period.
Chefaa - Pharmacy Delivery App showed modest weekly download numbers, peaking at 2.3K in the week of April 24. Active users for Chefaa remained fairly consistent, starting at 19.6K at the end of March and ending the quarter at 17.6K, with a slight increase to 21.3K in late April.
drug eye index maintained a stable download range between 1K and 1.7K, with a peak in the week of June 12. The app had a robust active user base, starting at 117.8K in late March and ending the quarter at 120.2K, showcasing consistent user engagement.
All the data presented is sourced from Sensor Tower, and more detailed insights can be found on their platform.